» back to Staff Publications
JUDITH RABKIN, MD, MPH
Selected peer-reviewed publications (in chronological order).
(Publications selected from 180 peer-reviewed publications).
Rabkin, JG, Remien, RH, Wilson C. Good Doctors, Good Patients: Partners in HIV Treatment. New York, NCM, 1994.
Rabkin, JG, Goetz, R, Remien, RH, Williams, JBW, Todak, G, Gorman, J. Mood and HIV illness progression in a cohort of HIV+ gay men. American Journal of Psychiatry, 1997; 154:231-238.
Rabkin, JG, Johnson, J, Lipsitz, J, Lin, H, Remien, RH, Williams, JBW, Gorman, J. Psychopathology in HIV+ and HIV- male and female intravenous drug users: Longitudinal course over 3 years. AIDS, 1997; 11:507- 515.
Rabkin, JG, Ferrando, S. DHEA: A possible therapeutic agent in HIV infection? AIDS Reader, 1997; 7:28-36.
Rabkin, JG, Ferrando, SJ, Jacobsberg, LB, Fishman, B. Prevalence of Axis I psychiatric disorders in an AIDS cohort: a controlled study. Comprehensive Psychiatry, 1997; 38:146-154.
Rabkin, JG, Ferrando, SJ. A “Second-Life” agenda: Psychiatric research issues raised by protease inhibitor treatments for people with HIV/AIDS. Archives of General Psychiatry, 1997; 54:1049-1053.
Rabkin, JG, Rabkin, R, Wagner, G. Review: Testosterone treatment of clinical hypogonadism in HIV/AIDS. International Journal of STD and AIDS, 1997; 8:537-545.
Rabkin, JG, Rabkin, R, Wagner, G. Prevalence and treatment of depressive disorders in HIV illness. Medscape Mental Health, 1997; 2(3) [Internet, unpaged].
Griffin, K, Rabkin, JG, Remien, RH, Williams, JB. Disease severity, physical limitations and depression in HIV-infected men. Journal of Psychosomatic Research, 1998; 44:219-227.
Ferrando SJ, Rabkin JG, Fishman B. Fatigue in HIV illness. Psychosomatic Medicine, 1998; 60:759-764.
Rabkin JG, Rabkin R, Wagner G. Testosterone therapy for HIV+ men with and without hypogonadism. Journal of Clinical Psychopharmacology, 1999; 19:19-27.
Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV/AIDS: A randomized placebo-controlled trial.American Journal of Psychiatry, 1999; 156:101-107.
Van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG. The relationship between employment and neuropsychological impairment in HIV infection. Journal of International Neuropsychological Society, 1999; 5:534-39.
Ferrando SJ, Rabkin JG, Poretsky L. Dehydroepiandrosterone and testosterone: Relationship to HIV illness stage and progression over one year. JAIDS & HR, 1999; 22:146-54.
Ferrando SJ, Rabkin JG, DeMoore G, Rabkin R. Treatment of Depression in HIV+ women. Journal of Clinical Psychiatry, 1999; 60:741-6.
Rabkin JG, Wagner G, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosomatic Medicine, 2000; 62:271-79.
Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF. Validity of clinical trials of antidepressants. American Journal of Psychiatry, 2000; 157:327-337.
Rabkin JG, Wagner G, Rabkin R. A double-blind placebo-controlled trial of testosterone therapy for HIV+ men with hypogonadal symptoms. Archives of General Psychiatry, 2000; 57:141-147.
Rabkin JG, Ferrando SJ, Van Gorp, W, Rieppi R, McElhiney M, Sewell M. Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. Journal of Neuropsychiatry and Clinical Neurosciences, 2000; 12:451-457.
Rabkin JG, McElhiney M, Ferrando S,. van Gorp W, Lin, S. Predictors of employment of men with HIV/AIDS: A longitudinal study. Psychosomatic Medicine, 2004; 66:72-78.
Adelman E, Albert S, Rabkin JG, Del Bene M, Tider T, O’Sullivan I. Disparities in perception of distress and burden in ALS patients and family caregivers. Neurology. 2004; 62:1766-1770.
Rabkin JG, Wagner G, McElhiney M, Rabkin R, Lin s. Testosterone vs. Fluoxetine for depression and fatigue in HIV/AIDS: A placebo controlled trial. J. Clinical Psychopharmacology. 2004, 24:379-385.
Rabkin JG, McElhiney M, Rabkin R, Ferrando SJ. Modafinil treatment of fatigue in HIV+ patients: A pilot study. J Clin Psychiatry. 2004, 65:1688-1695.
Haney M, Rabkin J, Gunderson E, Foltin R. Dronabinol and marijuana in HIV+ marijuana smokers: Effects on caloric intake and mood. Psychopharmacology. 2005; 181:170-178.
Rabkin JG, McElhiney M, Rabkin R, McGrath P, Ferrando S. Placebo-controlled trial of dehydroepiandrsterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. American Journal of Psychiatry, 2006; 163:1-8.
Rabkin JG, Albert S, Del Bene M, O’Sullivan I, Tider T, Rowland L, Mitsumoto H. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005; 65:62-67.
Albert SM, Rabkin JG, Del Bene M, Tider T, O’Sullivan I, Rowland L, Mitsumoto H. Wish to die in end-stage ALS. Neurology. 2005; 65: 68-74.
Rabkin JG, Albert S, Tider T, Del Bene M, O’Sullivan I, Rowland L, Mitsumoto H. Predictors and course of elective long-term mechanical ventilation: A prospective study of ALS patients. Amyotrophic Lateral Sclerosis. 2006; 7:86-95.
Mitsumoto H, Rabkin JG. Palliative care for patients with amyotrophic lateral sclerosis. JAMA. 2007; 298:207-216.
Rabkin JG, Albert SM. Family caregivers in ALS. In Mitsumoto H, ed, Amyotrophic lateral sclerosis: A guide for patients and families, 3rd ed, in press 2008.
Rabkin JG McElhiney M, Moran P, Acree M, Folkman S. Depression, distress and positive mood in late stage cancer: A longitudinal study. Psycho-oncology, in press, 2008.
Rabkin JG, Albert SM, Rowland LP, Mitsumoto H. How common is depression among ALS caregivers? A longitudinal study. Amyotrophic Lateral Sclerosis. In press, 2008.
Rabkin JG, Gordon P, McElhiney M, Rabkin R, Mitsumoto H. Modafinil treatment for fatigue in patients with amyotrophic lateral sclerosis: A placebo controlled study. Muscle and Nerve, in press. 2008.